Product type
Sunitinib Malate is a small molecule tyrosine kinase inhibitor used primarily in the treatment of certain types of cancer, including renal cell carcinoma and gastrointestinal stromal tumors. It works by inhibiting multiple receptor tyrosine kinases, which are involved in tumor growth and angiogenesis. This compound is typically supplied as a crystalline powder that is soluble in various solvents, allowing for formulation into oral dosage forms.
| Chemical formula | C22H26N2O4S |
| Molecular weight | 398.52 g/mol |
| Purity | ≥ 98% by HPLC |
| Solubility | Soluble in DMSO, ethanol, and methanol |
| Storage conditions | Store at 2-8°C, protected from light |
When selecting Sunitinib Malate, buyers should consider the required purity levels and the specific formulation needs for their applications. It's important to specify the desired quantity, as well as any necessary documentation such as Certificates of Analysis (CoA) and compliance with Good Manufacturing Practices (GMP). Buyers may also want to inquire about stability data and shelf life to ensure product efficacy.
Get quotes for Sunitinib Malate
Tell us your requirement — quantity, specs and timeline — and our team sources verified manufacturers and brings you the best quote.
It is primarily used as an anti-cancer treatment for renal cell carcinoma and gastrointestinal stromal tumors.
It is typically administered orally in capsule form.
It should be stored at 2-8°C, protected from light.
Purity is generally expected to be ≥ 98% by HPLC.
Yes, it is often used in combination with other cancer therapies, but this should be determined by a healthcare professional.
Common side effects include fatigue, nausea, and diarrhea, among others.